Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-15

FDA Approved: NADOLOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for Nadolol from Amneal Pharmaceuticals NY LLC under ANDA 208832, confirming the continued approval of this generic beta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nadolol (Nadolol)

Snippet

SUPPL AP for NADOLOL (NADOLOL)